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variability of coronary measurements was also assessed in 23 patients who
had 2 angiograms, a median of 21 days apart. The mean (±SD) of the dif-
ference between the 2 measurements was 0.09 ± 0.28 mm for RD, 0.06 ±
0.30 mm for MLD, 1.5 ± 9.1 % for OS, and 0.32 ± 1.7 mm for lesion length.
Less than 1 hour of training was needed for learning how to use this system
efficiently.
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OT dispersion from the 12 lead ECG has been extensively evaluated as a risk
parameter in pts prone to arrhythmias. Usually, this parameter is assessed
directly from the ECG tracing by means of a magnifying glass and a digitizing
pad with reproducibility and accuracy not being optimal.
We therefore developed a software program with a graphical interface per-
mitting conversion of a scanned image of the ECG on paper to a digital ECG
function (sampling rate 500 or 1000 Hz) which can then be analyzed by a sec-
ond interactive computer program for standard ECG intervals, OT dispersion
and other repolarization parameters (JTpeak, T areas, T peak to T end inter-
val). Digitally available ECGs can also be converted to a format analyzable by
the program.
The respective signals are processed channel-by-channel with enlarged
high resolution display on a 20" computer screen. The computer program
uses customized algorithms to detect important features of the ECG wave-
forms (0 onset. J point, T peak, and T end for ECG signals) and then displays
colored vertical spikes superimposed on the signal marking these points with
high resolution for confirmation or manual correction by the observer. The
processed data are automatically written to a spreadsheet for further pro-
cessing.
With this methodology accuracy and reproducibility of OT intervals and
ECG parameters of dispersion of repolarization can be increased and param-
eters not easily measurable on paper can be determined (T wave areas).
7 Months 12 Months
Stent Balloon Stent Balloon
Death 2 (0.8%) 1(0.4%) 3(1.2%) 1 (0.4%)
Stroke 0 2(08%) 0 2(0.8%)
MI 11 (4.2%) 10(3.9%) 13(5.0%) 11 (4.3%)
CABG 13(5.0%) 10(3.9%) 18(6.9%) 13(5.1%)
Re-PTCA 26 (10.0%) 53 (210%)" 26 (10.0%) 54 (21.0%1"
Any 52 (20.0%) 76(30.0%~ 60 (23.0%) 81131.5%f>
c:J Relative rIsk (RR) 0.48, 95% CI (0.31-0.74), p = 0.001: • RR 068, 95% CI (0.50-0.92),
P ~ 0.02; <> RR 0.74, 95% CI (055-098), p = 0.04
This FU clinical data suggest that the benefit of elective coronary stenting
is maintained at least for 1 year and results from a significantly reduced need
for repeat PTCA.
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LAD PTCA LAD S Non-LAD PTCA Non-LAD S
N ~ 98 N ~ 96 N ~ 104 N = 109
Final % stenosis 34 ± 15 17 ± 11t 35 ± 14 20 ± 121
Acute gain (mm) , .14 ± 0.47 162 ± 0.431 1.32 ± 049 181 ± 0.471
Late Loss (mm) 0.52 ± 0.55 0.78 ± 0.57* 034 ± 0.57 0.73 ± 0.571
Net gain (mm) 0.59 ± 055 0.88 ± 0.62* 1.03 ± 0.61 1.06 ± 0.61
RES (>50% stenosIs) 52.6 329* 299 295
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The Benestent Trial is a randomized study comparing elective Palmaz-Schatz
stent implantation vs balloon angioplasty in de novo lesions in patients with
stable angina. Data at 7 months have shown a decreased restenosis rate and
reduced clinical events in the Stent group. However, it is not established if
this favourable clinical outcome is maintained at one year. Consequently we
have updated clinical information from 516 patients enrolled in the Benestent
Trial (257 PTCA; 259 Stent). FU information was obtained in all but 4 patients
12 in the Stent group and 2 in the Balloon groupl. Mean follow-up was 12
months (0.3-34 months). At FU no differences were found in the 2 groups
with respect to medications and functional class (CCS). Major clinical events
are tabulated according to the Intention to treat principle and assigning each
patient only the highest ranked event.
*P OS 0.01, Ip OS 0.0001 compared Swith PTCA
In both LAD and non-LAD vessels, S (compared with PTCA) achieved a
greater acute ga in and resulted in a lower final % stenosis. Late loss was
also greater in S than PTCA group and similar for LAD and non-LAD vessels.
However, in PTCA pts, late loss was much lower in non-LAD vessels (vs LAD).
Thus, the overall net gain and RES in non-LAD vessels were similar for Sand
PTCA, whereas the net gain was greater after S in LAD vessels and resulted
in much lower RES compared with PTCA. Similarly, the difference in event-
free survival (freedom from death, MI, CABG, or repeat PTCA) between S
and PTCA was greater in LAD (77% vs 66%, P = 0.06) than non-LAD vessels
178% vs 72%, NS). In Conclusion: STRESS substudy analysis indicates 1) S
provides uniformly greater improvement of angiographic results in all lesion
locations compared with PTCA, 2) much greater anti-restenosis and clinical
benefits in S pts within the LAD vessels, and 3) more aggressive post-S di-
latation strategies (to further reduce final % stenosis) are recommended for
non-LAD vessels to achieve greater differential anti-restenosis benefit for S.
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In the multicenter randomized STent REStenosis Study (STRESS I, stent (S)
implantation has shown to reduce restenosis (RES) by 26% compared with
PTCA. To determine the impact of S vs PTCA in reducing RES in various vessel
locations, we analyzed the data from STRESS in LAD and non-LAD vessels.
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We have used a commercially available personal digital assistant(PDAl.
equipped with Xl type processor, MS-DOS 5.0 system, 1 Mb RAM memory
and 10Mb PCMCIA RAM card. Hospital patient(pt) data was acquired into
WP 5.1 wordprocessor(WP) using form files and macro programs to assure
standard format and complete data set for each pt. The PDA is backed by a
desk-top computer (PC) via a null modem serial interface. The pt record can
be selectively printed and immediately placed in the chart as a formal history
and physical (H&Pl. daily notes or a discharge summary, thus obViating fre-
quently illegible handwritten notes. The PDA records can be integrated with
the PC out patient records by using prompted dialog box. Through Wordper-
fect's 6.0 new feature, quickfinder index(OI) the pt's records can be viewed
as an electronic chart derived from subdirectories of different procedures,
tests, evaluations, etc .. The 01 allows search and retrieval of specific infor-
mation for an individual or groups of pts.
Advantages of this new integrated system are: 1) Standardization of data
entry and data integrity; 2) Access to pt data independent of the chart; 31
Ability to retrieve and report selected information; 4) Rapid, concise and ac-
curate formulation of H&P. daily notes and discharge summary with imme-
diate printout; 5) Updated office file; 61 Instantaneous recall of information
of readmitted pts; 7) Accurate billing information; 8) Oueries derived from
the integrated hospital and office electronic chart assist in clinical decision
making and improve the quality of care of individual as well as subsets of
cardiac pts.
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